5 enrolling by invitation. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Enrolling by invitation 5 |
Follow Liver Diseases: new trials by email Literature Review of Liver Diseases trials Research Report on Liver Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) early time restricted Mediterranean diet, Mysimba - Diabetes Mellitus, Type 2, Liver Fibrosis | Phase 4 | Enrolling by invitation | Carmen Dietvorst | 70 | 2025-04-14 | 2026-04-21 |
| TAF in Early/Middle Pregnancy With CHB TAF, TDF - Hepatitis B Infection, Pregnant Women | Phase 4 | Enrolling by invitation | The Third Affiliated Hospital of Guangzhou Medical University | 816 | 2025-03-31 | 2026-06-25 |
| TAF vs TDF During the Pregancy TAF - Hepatitis B Virus Infection; Pregnant Women | Phase 4 | Enrolling by invitation | The Third Affiliated Hospital of Guangzhou Medical University | 210 | 2024-12-27 | 2026-10-16 |
| Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria Atezolizumab, Bevacizumab - Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 4 | Enrolling by invitation | The Methodist Hospital Research Institute | 24 | 2023-01-30 | 2026-10-08 |
| Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer Everolimus, Tacrolimus, Myfortic - Carcinoma, Hepatocellular | Phase 4 | Enrolling by invitation | Baylor Research Institute | 336 | 2014-03-01 | 2026-01-27 |
Carcinoma, Hepatocellular (2) · Hepatitis B (2) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Fatty Liver (1) · Hypertension (1) · Intermittent Fasting (1) · Liver Cirrhosis (1) · Liver Neoplasms (1) · Obesity (1) · Overweight (1)
Digestive System Diseases (5) · Adenocarcinoma (2) · Blood-Borne Infections (2) · Carcinoma (2) · Communicable Diseases (2) · DNA Virus Infections (2) · Digestive System Neoplasms (2) · Hepadnaviridae Infections (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Infections (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2)
Azathioprine (1) · Bevacizumab (1) · Bupropion (1) · Diet Therapy (1) · Diet, Mediterranean (1) · Everolimus (1) · Mycophenolic Acid (1) · Naltrexone (1) · Tacrolimus (1) · Tenofovir (1) · atezolizumab (1) · bupropion hydrochloride, naltrexone hydrochoride drug combination (1) · tenofovir alafenamide (1)
The Third Affiliated Hospital of Guangzhou Medical University (2) · Baylor Research Institute (1) · Carmen Dietvorst (1) · The Methodist Hospital Research Institute (1)
China (2) · United States (2) · Canada (1) · Netherlands (1)
Goran Klintmalm, MD, PhD (1) · Manuel Castro Cabezas, Dr. (1) · Panpan Zhai (1)